| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Parvinder Thiara is Director at ZURA. Parvinder Thiara's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Historically, Parvinder Thiara's trades have earned a middling insider score of 61/100 across 3 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +20.3%.
Parvinder Thiara has 7 Form 4 filings on record from December 2023 to June 2026, all as Director at Zura Bio (ZURA), 2023–2026.
The 7 reported transactions were 4 option or other derivative awards and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $21.0M.
The largest open-market sale was 3,800,000 shares of ZURA at an average $2.70 on September 11, 2024, about $10.3M. Twelve months later ZURA was down 42%.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | ZURA Zura Bio Ltd | Director | Sell | 1,001,633 | $2.73 | $2,734,458.09 | -100% | -56.9% | +22.5% | |
| Sep 11, 2024 | ZURA Zura Bio Ltd | - | Sell | 3,800,000 | $2.70 | $10,260,000.00 | -79.1% | -20.6% | -42.3% | |
| Dec 12, 2023 | ZURA Zura Bio Ltd | Director, 10% Owner | Sell | 2,000,000 | $4.00 | $8,000,000.00 | -29.4% | -24.4% | -41.2% |